Motivation Project: Testing Intervention Components for the Smoker Who is Unwilling to Quit
17. září 2020 aktualizováno: University of Wisconsin, Madison
Optimized Chronic Care for Smokers: A Comparative Effectiveness Approach; Motivation Project: Testing Intervention Components for the Smoker Who is Unwilling to Quit
The ultimate goal of this research is to develop a chronic care treatment package for smokers that will address the challenges and opportunities of each phase of the cessation process - motivation, preparation, cessation, maintenance, and relapse recovery.
That is, to develop treatments for smokers not yet ready to quit, those who are preparing to quit, those actively engaged in the quitting process and those who have tried to quit but relapsed.
To achieve this goal, this research comprises three distinct research studies, each of which represent a phase in a comprehensive chronic care treatment model for clinical intervention with smokers in the primary care setting: the Motivation Study, the Cessation Study, and the Long-term Quitting Study.
The goal of each study is to test and identify effective intervention components for distinct phases of the smoking cessation process.
These components will then be combined for future research on the effectiveness of this chronic care treatment package.
This study is a 2x2x2x2 factorial design.
Participants will be randomized to one of two levels on four different factors: 1) Nicotine Mini-Lozenge vs.
No Mini-Lozenge, 2) Behavioral Reduction Counseling (intervention: BR) vs.
No Behavioral Reduction Counseling, 3) 5Rs Motivation Counseling (intervention 5 R's) vs.
No 5Rs Motivation Counseling, and 4) Behavioral Activation Counseling (intervention BA) vs.
No Behavioral Activation Counseling.
These components have strong theoretical and empirical support, but their relative, additive, and interactive effects are unknown.
Přehled studie
Postavení
Dokončeno
Podmínky
Typ studie
Intervenční
Zápis (Aktuální)
577
Fáze
- Fáze 4
Kontakty a umístění
Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.
Studijní místa
-
-
Wisconsin
-
Madison, Wisconsin, Spojené státy, 53711-2027
- University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health
-
-
Kritéria účasti
Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.
Kritéria způsobilosti
Věk způsobilý ke studiu
18 let a starší (Dospělý, Starší dospělý)
Přijímá zdravé dobrovolníky
Ne
Pohlaví způsobilá ke studiu
Všechno
Popis
Inclusion Criteria:
- age >=18 years; smoking >4 cigarettes/day for the previous 6 months; able to read, write, and speak English; have reliable phone access and agree to respond to Interactive Voice Response (IVR) phone prompts; and if currently using NRT, agreeing to use only study medication for the duration of the study. We will not exclude participants based on their prior use of cessation medication or if they use multiple tobacco products in order to enhance real-world generalization (these will be statistically controlled in analyses); not currently attempting to quit smoking; not intending to quit smoking (defined as no plans to quit in the next month); and planning to remain in the intervention catchment area for at least 12 months.
Exclusion Criteria:
- currently taking bupropion or varenicline; medical contraindications to using NRT including hospitalized (for at least one night) for a stroke, heart attack, congestive heart failure or diabetes in the last 30 days; diagnosis of or treatment for schizophrenia, a psychotic disorder or bipolar disorder in the last 10 years; and, if the participant is a woman of childbearing potential, being pregnant or intending to becoming pregnant or unwillingness to use an approved method of birth control during treatment.
Studijní plán
Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Faktorové přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Mini-Lozenge, BR, 5Rs, BA
1; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, BR, 5Rs, BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Experimentální: Mini-Lozenge, BR, 5Rs, No BA
2; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, BR, 5Rs, No BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
|
|
Experimentální: Mini-Lozenge, BR, No 5Rs, BA
3; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, BR, No 5Rs, BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Experimentální: Mini-Lozenge, BR, No 5Rs, No BA
4; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, BR, No 5Rs, No BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
|
|
Experimentální: Mini-Lozenge, No BR, 5Rs, BA
5; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, No BR, 5Rs, BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Experimentální: Mini-Lozenge, No BR, 5Rs, No BA
6; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, No BR, 5Rs, No BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
|
|
Experimentální: Mini-Lozenge, No BR, No 5Rs, BA
7; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, No BR, No 5Rs, BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Experimentální: Mini-Lozenge, No BR, No 5Rs, No BA
8; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, No BR, No 5Rs, No BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
|
|
Experimentální: No Mini-Lozenge, BR, 5Rs, BA
9; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, BR, 5Rs, BA
|
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Experimentální: No Mini-Lozenge, BR, 5Rs, No BA
10; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, BR, 5Rs, No BA
|
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
|
|
Experimentální: No Mini-Lozenge, BR, No 5Rs, BA
11; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, BR, No 5Rs, BA
|
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Experimentální: No Mini-Lozenge, BR, No 5Rs, No BA
12; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, BR, No 5Rs, No BA
|
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
|
|
Experimentální: No Mini-Lozenge, No BR, 5Rs, BA
13; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, No BR, 5Rs, BA
|
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Experimentální: No Mini-Lozenge, No BR, 5Rs, No BA
14; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, No BR, 5Rs, No BA
|
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
|
|
Experimentální: No Mini-Lozenge, No BR, No 5Rs, BA
15; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, No BR, No 5Rs, BA
|
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Experimentální: No Mini-Lozenge, No BR, No 5Rs, No BA
16; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, No BR, No 5Rs, No BA
|
Žádná léčba
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
7-Day Point-Prevalence Abstinence
Časové okno: 12 months
|
Participants who self-report no smoking for the past 7 days at the assessment endpoint (12 month follow-up) will be considered to meet criteria for 7-Day Point-Prevalence Abstinence.
Participants who who report any smoking in the past 7 days (at the 12 month follow-up) will be considered to be relapsed (smoking).
|
12 months
|
Spolupracovníci a vyšetřovatelé
Zde najdete lidi a organizace zapojené do této studie.
Sponzor
Spolupracovníci
Vyšetřovatelé
- Studijní židle: Michael C Fiore, MD, MPH, MBA, University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health
- Ředitel studie: Jessica Cook, PhD, University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health
- Vrchní vyšetřovatel: Robin Mermelstein, PhD, Institute for Health Research and Policy, University of Illinois at Chicago
Publikace a užitečné odkazy
Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.
Termíny studijních záznamů
Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.
Hlavní termíny studia
Začátek studia (Aktuální)
1. ledna 2015
Primární dokončení (Aktuální)
19. března 2019
Dokončení studie (Aktuální)
19. března 2019
Termíny zápisu do studia
První předloženo
22. ledna 2015
První předloženo, které splnilo kritéria kontroly kvality
29. ledna 2015
První zveřejněno (Odhad)
3. února 2015
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
22. září 2020
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
17. září 2020
Naposledy ověřeno
1. září 2020
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 2014-1041Motivation
- A534252 (Jiný identifikátor: UW Madison)
- CTRI (Jiný identifikátor: UW Madison)
- SMPH\MEDICINE\TOBACCO RE (Jiný identifikátor: UW Madison)
- 1P01CA180945-01 (Grant/smlouva NIH USA)
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Ne
Studuje produkt zařízení regulovaný americkým úřadem FDA
Ne
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Žádná léčba
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)NáborPoruchou autistického spektra | AutismusSpojené státy
-
Stanford UniversityDokončenoZlepšení přístupu k Pivotal Response Treatment (PRT) prostřednictvím telehealth rodičovského školeníPoruchou autistického spektraSpojené státy
-
Virginia Polytechnic Institute and State UniversityDokončenoPoruchou autistického spektraSpojené státy
-
Stanford UniversityUniversity of California, Santa BarbaraZatím nenabírámePoruchou autistického spektra
-
The Cleveland ClinicTwin HealthAktivní, ne nábor
-
Stanford UniversityDokončenoSocial Motivation Intervention for Children With Autism Spectrum Disorder: Improving Peer InitiationPoruchou autistického spektraSpojené státy
-
Yale UniversitySimons FoundationDokončeno
-
CSA Medical, Inc.UkončenoBarrettův jícen | Dysplazie nízkého stupně | Dysplazie vysokého stupněSpojené státy
-
University of PittsburghNational Institute of Mental Health (NIMH)NáborSebevražda | ÚmrtíSpojené státy
-
Otsuka Pharmaceutical Factory, Inc.CelerionDokončeno